de Bruin-Weller MS - Search Results

1

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.

Ring J, Worm M, Wollenberg A, Thyssen JP, Jakob T, Klimek L, Bangert C, Barbarot S, Bieber T, de Bruin-Weller MS, Chernyshov PV, Christen-Zaech S, Cork M, Darsow U, Flohr C, Fölster-Holst R, Gelmetti C, Gieler U, Gutermuth J, Heratizadeh A, Hijnen DJ, von Kobyletzki LB, Kunz B, Paul C, De Raeve L, Seneschal J, Simon D, Spuls PI, Stalder JF, Svensson A, Szalai Z, Taieb A, Torrelo A, Trzeciak M, Vestergaard C, Werfel T, Weidinger S, Deleuran M. Ring J, et al. J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e362-e365. doi: 10.1111/jdv.17237. Epub 2021 Apr 3. J Eur Acad Dermatol Venereol. 2021. PMID: 33752263 Free PMC article. No abstract available.

2

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E. Hijnen D, et al. J Allergy Clin Immunol. 2004 Feb;113(2):334-40. doi: 10.1016/j.jaci.2003.12.007. J Allergy Clin Immunol. 2004. PMID: 14767451

3

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

Oldhoff JM, Darsow U, Werfel T, Katzer K, Wulf A, Laifaoui J, Hijnen DJ, Plötz S, Knol EF, Kapp A, Bruijnzeel-Koomen CA, Ring J, de Bruin-Weller MS. Oldhoff JM, et al. Allergy. 2005 May;60(5):693-6. doi: 10.1111/j.1398-9995.2005.00791.x. Allergy. 2005. PMID: 15813818 Clinical Trial.

4

No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.

Oldhoff JM, Darsow U, Werfel T, Bihari IC, Katzer K, Laifaoui J, Plötz S, Kapp A, Knol EF, Bruijnzeel-Koomen CA, Ring J, de Bruin-Weller MS. Oldhoff JM, et al. Int Arch Allergy Immunol. 2006;141(3):290-4. doi: 10.1159/000095299. Epub 2006 Aug 23. Int Arch Allergy Immunol. 2006. PMID: 16931891 Clinical Trial.

5

Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.

Hijnen DJ, ten Berge O, Timmer-de Mik L, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Hijnen DJ, et al. J Eur Acad Dermatol Venereol. 2007 Jan;21(1):85-9. doi: 10.1111/j.1468-3083.2006.01877.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17207173

6

Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.

Haeck IM, Timmer-de Mik L, Lentjes EG, Buskens E, Hijnen DJ, Guikers C, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Haeck IM, et al. Br J Dermatol. 2007 May;156(5):979-85. doi: 10.1111/j.1365-2133.2007.07753.x. Epub 2007 Feb 12. Br J Dermatol. 2007. PMID: 17298484 Free article.

7

Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients.

Hijnen DJ, Knol E, Bruijnzeel-Koomen C, de Bruin-Weller M. Hijnen DJ, et al. Dermatitis. 2007 Sep;18(3):163-5. doi: 10.2310/6620.2007.06025. Dermatitis. 2007. PMID: 17725924

8

Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis.

Haeck IM, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol MJ. Haeck IM, et al. J Eur Acad Dermatol Venereol. 2012 Feb;26(2):236-41. doi: 10.1111/j.1468-3083.2011.04043.x. Epub 2011 Mar 24. J Eur Acad Dermatol Venereol. 2012. PMID: 22280511

9

Modulation of lymphocyte function in vivo via inhibition of calcineurin or purine synthesis in patients with atopic dermatitis.

Knol EF, Haeck IM, van Kraats AA, Laaper-Ertmann M, Giovannone B, Hijnen D, Nijhuis E, de Bruin-Weller MS, Knol MJ, Bruijnzeel-Koomen CA. Knol EF, et al. J Invest Dermatol. 2012 Oct;132(10):2476-2479. doi: 10.1038/jid.2012.150. Epub 2012 May 24. J Invest Dermatol. 2012. PMID: 22622424 Free article. Clinical Trial. No abstract available.

10

Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity.

Landheer J, de Bruin-Weller M, Boonacker C, Hijnen D, Bruijnzeel-Koomen C, Röckmann H. Landheer J, et al. J Am Acad Dermatol. 2014 Dec;71(6):1160-6. doi: 10.1016/j.jaad.2014.07.031. Epub 2014 Sep 4. J Am Acad Dermatol. 2014. PMID: 25199679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page